Cytokinetics (CYTK) had the highest return between December 5, 2023 and December 30, 2023 by a mid-cap US stock, returning 148.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Cytokinetics (CYTK) | 12/5/2023 - 12/30/2023 | 148.33% |
Sezzle (SEZL) | 12/5/2023 - 12/30/2023 | 106.24% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 12/5/2023 - 12/30/2023 | 86.04% |
Aurora Innovation (AUR) | 12/5/2023 - 12/30/2023 | 78.37% |
Edgewise Therapeutics (EWTX) | 12/5/2023 - 12/30/2023 | 69.35% |
Compania de Minas Buenaventura SAA ADR (BVN) | 12/5/2023 - 12/30/2023 | 64.05% |
Liquidia Technologies (LQDA) | 12/5/2023 - 12/30/2023 | 62.79% |
GeneDx (WGS) | 12/5/2023 - 12/30/2023 | 58.05% |
Compass (COMP) | 12/5/2023 - 12/30/2023 | 52.23% |
Terawulf (WULF) | 12/5/2023 - 12/30/2023 | 50% |
Century Aluminum (CENX) | 12/5/2023 - 12/30/2023 | 48.59% |
CommScope (COMM) | 12/5/2023 - 12/30/2023 | 46.88% |
Arcutis Biotherapeutics (ARQT) | 12/5/2023 - 12/30/2023 | 44.84% |
Soleno Therapeutics (SLNO) | 12/5/2023 - 12/30/2023 | 43.96% |
Apogee Therapeutics, Inc Common Stock (APGE) | 12/5/2023 - 12/30/2023 | 39.98% |
Xometry (XMTR) | 12/5/2023 - 12/30/2023 | 39.73% |
Sunrun (RUN) | 12/5/2023 - 12/30/2023 | 39.42% |
Praxis Precision Medicines (PRAX) | 12/5/2023 - 12/30/2023 | 39.25% |
ACADIA Pharmaceuticals (ACAD) | 12/5/2023 - 12/30/2023 | 37.99% |
Cipher Mining (CIFR) | 12/5/2023 - 12/30/2023 | 37.21% |
Immunome (IMNM) | 12/5/2023 - 12/30/2023 | 36.31% |
Sterling Construction (STRL) | 12/5/2023 - 12/30/2023 | 35.84% |
Immunitybio (IBRX) | 12/5/2023 - 12/30/2023 | 35.68% |
Sprint Communications (S) | 12/5/2023 - 12/30/2023 | 34.51% |
Recursion Pharmaceuticals (RXRX) | 12/5/2023 - 12/30/2023 | 34.15% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
